{"id":1634,"date":"2007-10-21T14:55:43","date_gmt":"2007-10-21T14:55:43","guid":{"rendered":"http:\/\/localhost:8888\/wordpress\/zelnorm_a_dangerous_drug_1\/"},"modified":"2024-12-17T16:11:23","modified_gmt":"2024-12-17T21:11:23","slug":"zelnorm-a-dangerous-drug-1","status":"publish","type":"post","link":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/","title":{"rendered":"Zelnorm \u00ae &#8211; A Dangerous Drug?"},"content":{"rendered":"<p>As a Georgia injury lawyer, I am always reading about <a href=\"http:\/\/www.georgiainjurylawyerblog.com\/dangerous_drugs\/\">dangerous drugs<\/a>. One such drug is Zelnorm \u00ae , a drug used in the treatment of Irritable Bowel Syndrom (\u201cIBS\u201d) and chronic constipation in individuals under 65 years of age.<\/p>\n<p>On March 30, 2007, the FDA requested that Novartis Pharmaceuticals Corporation (\u201cNovartis\u201d), the manufacturer of Zelnorm, voluntarily remove the drug from the market.  The recall is based on findings of an increased risk of heart attacks and strokes associated with the drug from clinical trials recently reported by Novartis.<\/p>\n<p>Novartis reported to the FDA the results of a new analysis of 29 short term randomized, controlled clinical trials of Zelnorm.  The analysis included more than 11, 000 patients treated with Zelnorm and over 700 patients treated with Placebo.  The data showed the serious risk of cardiovascular adverse events associated with Zelnorm to be higher than the Placebo treatment.  Thirteen patients treated with Zelnorm had confirmed cardiovascular ischemic events and only 1 Placebo treated patient experienced a cardiovascular event.<\/p>\n<div class=\"read_more_link\"><a href=\"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/\"  title=\"Continue Reading Zelnorm \u00ae &#8211; A Dangerous Drug?\" class=\"more-link\">Continue reading<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>As a Georgia injury lawyer, I am always reading about dangerous drugs. One such drug is Zelnorm \u00ae , a drug used in the treatment of Irritable Bowel Syndrom (\u201cIBS\u201d) and chronic constipation in individuals under 65 years of age. On March 30, 2007, the FDA requested that Novartis Pharmaceuticals Corporation (\u201cNovartis\u201d), the manufacturer of [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[40],"tags":[44],"class_list":["post-1634","post","type-post","status-publish","format-standard","hentry","category-personal-injury-wrongful-death","tag-personal-injury"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zelnorm \u00ae - A Dangerous Drug? &#8212; Trial Attorney Blog &#8212; October 21, 2007<\/title>\n<meta name=\"description\" content=\"As a Georgia injury lawyer, I am always reading about dangerous drugs. One such drug is Zelnorm \u00ae , a drug used in the treatment of Irritable Bowel &#8212; October 21, 2007\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Zelnorm \u00ae - A Dangerous Drug? &#8212; Trial Attorney Blog &#8212; October 21, 2007\" \/>\n<meta name=\"twitter:description\" content=\"As a Georgia injury lawyer, I am always reading about dangerous drugs. One such drug is Zelnorm \u00ae , a drug used in the treatment of Irritable Bowel &#8212; October 21, 2007\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Finch McCranie, LLP\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zelnorm \u00ae - A Dangerous Drug? &#8212; Trial Attorney Blog &#8212; October 21, 2007","description":"As a Georgia injury lawyer, I am always reading about dangerous drugs. One such drug is Zelnorm \u00ae , a drug used in the treatment of Irritable Bowel &#8212; October 21, 2007","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/","twitter_card":"summary_large_image","twitter_title":"Zelnorm \u00ae - A Dangerous Drug? &#8212; Trial Attorney Blog &#8212; October 21, 2007","twitter_description":"As a Georgia injury lawyer, I am always reading about dangerous drugs. One such drug is Zelnorm \u00ae , a drug used in the treatment of Irritable Bowel &#8212; October 21, 2007","twitter_misc":{"Written by":"Finch McCranie, LLP","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/#article","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/"},"author":{"name":"Finch McCranie, LLP","@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4"},"headline":"Zelnorm \u00ae &#8211; A Dangerous Drug?","datePublished":"2007-10-21T14:55:43+00:00","dateModified":"2024-12-17T21:11:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/"},"wordCount":222,"keywords":["Personal Injury"],"articleSection":["Personal Injury &amp; Wrongful Death"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/","url":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/","name":"Zelnorm \u00ae - A Dangerous Drug? &#8212; Trial Attorney Blog &#8212; October 21, 2007","isPartOf":{"@id":"https:\/\/www.finchmccranie.com\/blog\/#website"},"datePublished":"2007-10-21T14:55:43+00:00","dateModified":"2024-12-17T21:11:23+00:00","author":{"@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4"},"description":"As a Georgia injury lawyer, I am always reading about dangerous drugs. One such drug is Zelnorm \u00ae , a drug used in the treatment of Irritable Bowel &#8212; October 21, 2007","breadcrumb":{"@id":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.finchmccranie.com\/blog\/zelnorm-a-dangerous-drug-1\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.finchmccranie.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Zelnorm \u00ae &#8211; A Dangerous Drug?"}]},{"@type":"WebSite","@id":"https:\/\/www.finchmccranie.com\/blog\/#website","url":"https:\/\/www.finchmccranie.com\/blog\/","name":"Trial Attorney Blog","description":"Published by Georgia Trial Lawyers \u2014 Finch McCranie, LLP","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.finchmccranie.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.finchmccranie.com\/blog\/#\/schema\/person\/4c607d19a3fdb947c462210c077ff4a4","name":"Finch McCranie, LLP","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/0ac10eb5fe0f322f70ad7a84f6c73584e7381799013c841fb9f2ecf347e28d71?s=96&d=mm&r=g","caption":"Finch McCranie, LLP"}}]}},"jetpack_featured_media_url":"","_links":{"self":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/comments?post=1634"}],"version-history":[{"count":2,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1634\/revisions"}],"predecessor-version":[{"id":33766,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/posts\/1634\/revisions\/33766"}],"wp:attachment":[{"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/media?parent=1634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/categories?post=1634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.finchmccranie.com\/blog\/wp-json\/wp\/v2\/tags?post=1634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}